Clinical Trials Directory

Trials / Unknown

UnknownNCT04753008

Respiratory Effects of Dopamine in the Perioperative Care

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Szeged University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

Dopamine is frequently used as an inotropic drug to elevate cardiac output. In addition to the beneficial cardiac effect of this drug, the few previous studies addressing its ability to alter the airway tone reported controversial results. Thus, the investigators aimed at clarifying the potential of dopamine to alter gas exchange outcomes and the airway tone in patients undergoing cardiac surgeries with cardiopulmonary bypass. Blood gas parameters, airway resistance, tissue damping and tissue elastance will be measured in the patients before the CPB, immediately after CPB, and 5 min after administration of dopamine (3 mcg/kg/min). The importance of the research is to reveal whether the beneficial mechanical changes after dopamine administrations are associated with improvements in gas exchange outcomes. Clarification of this research question have scientific relevance and may also improves patient outcomes.

Conditions

Interventions

TypeNameDescription
DRUGDopamine administrationAdministration of dopamine (3 mcg/kg/min) as part of cardiac support therapy after the cardiopulmonary bypass. Administration of dopamine is a subject of clinical decision based on the cardiovascular status of the patients.

Timeline

Start date
2010-12-13
Primary completion
2021-03-31
Completion
2021-12-31
First posted
2021-02-12
Last updated
2021-02-12

Locations

1 site across 1 country: Hungary

Source: ClinicalTrials.gov record NCT04753008. Inclusion in this directory is not an endorsement.

Respiratory Effects of Dopamine in the Perioperative Care (NCT04753008) · Clinical Trials Directory